# Gluten in Drug Products and Associated Labeling Recommendations; Draft Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/gluten-in-drug-products-and-associated-labeling-recommendations-draft-guidance-for-industry/7c089d7c-0cae-4796-899d-09c5a25a376f

> FDA guidance document: Gluten in Drug Products and Associated Labeling Recommendations; Draft Guidance for Industry. Issue date: December 12, 2017. Get complete insights and analysis.

---

## Details

- Title: Gluten in Drug Products and Associated Labeling Recommendations; Draft Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2017-12-12
- Comment Close Date: 2018-03-12
- Last Changed: 2020-04-22
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2017-D-6352">FDA-2017-D-6352</a>

## Related Documents

- [Drug Master Files Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/drug-master-files-guidance-for-industry/7dfd5140-3156-43f2-bdb9-d23ad597311c)
- [Labeling for Biosimilar and Interchangeable Biosimilar Products](https://www.globalkeysolutions.net/guidances/guidance-document/labeling-for-biosimilar-and-interchangeable-biosimilar-products/54a5f712-03f5-4993-b0d7-6a1c2f261eff)
- [Nonproprietary Naming of Biological Products: Update Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/nonproprietary-naming-of-biological-products-update-guidance-for-industry/8adaef5a-6903-4e65-ac57-121d51429730)